CNS Pharmaceuticals COO Dylan Wenke joins investor segment discussion
CNS Pharmaceuticals said Chief Business Officer Dylan Wenke participated in a virtual investor "What This Means" segment on TradingView News.
Chief Business Officer, Dylan Wenke, Participates in Virtual Investor "What This Means" SegmentAccess the segment hereHOUSTON, TX / / September 1, 2026 / CNS Pharmaceuticals, Inc.
NASDAQ:CNSP ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovat…